ABRHIGH SIGNALFINANCIAL10-K

ABR experienced a substantial deterioration in profitability driven by dramatically higher interest expenses despite expanding its loan portfolio and launching new construction lending services.

The company's interest expense grew substantially while net income and operating income declined meaningfully, indicating significant margin compression likely due to rising funding costs in a higher rate environment. This pressure on profitability occurred even as ABR expanded its business by adding construction lending capabilities and growing its debt portfolio by 11.2%, suggesting the company is struggling to maintain profitability while scaling operations.

Comparing 2026-02-27 vs 2025-02-21View on EDGAR →
FINANCIAL ANALYSIS

ABR's financial performance deteriorated notably with interest expense increasing substantially to $903.2M while net income fell 43% to $53.4M and operating income declined 41% to $176.6M. Total debt grew 11.2% to $11.1B as the company expanded its lending portfolio, but operating cash flow declined 19% to $372.4M. The combination of higher funding costs, reduced profitability, and lower cash generation despite portfolio growth signals meaningful pressure on the company's lending margins and operational efficiency.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-82.4%
$11.4M$2.0M

Buyback activity reduced 82.4% — capital being redeployed elsewhere or cash conservation underway.

Interest Expense
P&L
+62%
$557.6M$903.2M

Interest expense surged 62% — significant debt increase or rising rates materially impacting earnings.

Net Income
P&L
-42.6%
$93.0M$53.4M

Net income declined 42.6% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-40.6%
$297.4M$176.6M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Operating Cash Flow
Cash Flow
-19.3%
$461.5M$372.4M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Total Debt
Balance Sheet
+11.2%
$10.0B$11.1B

Debt rose 11.2% — additional borrowing for investment or operations; monitor coverage ratios.

Total Liabilities
Balance Sheet
+10.5%
$10.3B$11.4B

Liabilities increased 10.5% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-21
ADDED
As of February 20, 2026, the registrant had 193,115,316 shares of common stock outstanding.
We offer construction lending through our Arbor Private Construction program, offering multifamily investors short-term floating-rate financing for new and construction-ready multifamily projects for experienced sponsors and projects located in major metropolitan areas.
Our construction lending also complements our SFR lending program by expanding our ability to support borrowers across both multifamily and single-family rental housing strategies.
We may also require additional security such as personal guarantees, letters of credit and/or additional collateral unrelated to the property.
The loans are subsequently sold to third-party investors while retaining mortgage servicing.
+7 more — sign up free →
REMOVED
As of February 14, 2025, the registrant had 189,505,422 shares of common stock outstanding.
The loans are subsequently sold to third party investors while retaining mortgage servicing.
The overall yield on our loan and investment portfolio in 2024 was 9.01% on average assets of $11.98 billion, which was computed by dividing the interest income earned during 2024 by the average assets during 2024.
Our cost of funds in 2024 was 7.44% on average borrowings of $10.48 billion, which was computed by dividing the interest expense incurred during 2024 by the average borrowings during 2024.
At December 31, 2024, our loan and investment portfolio was comprised of 92% floating rate loans and 8% fixed rate loans.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →